Highly specific new antibody introduced to boost HER2 type cancer research

A highly specific HER3 rabbit monoclonal antibody (mAb) developed by use-based Cell Signaling Technology could provide important new information for researchers studying HER2-mediated breast, lung and ovarian tumours.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news